Elanco Animal Health Incorporated Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Elanco Animal Health Incorporated (ELAN) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $37.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-02-24
- Elanco Animal Health Incorporated unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $37.00M, a 428.57% increase from fiscal 2024.
- Elanco Animal Health Incorporated unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $7.00M, a 250.00% increase from fiscal 2023.
- Elanco Animal Health Incorporated unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $2.00M, a 33.33% decline from fiscal 2022.
- Elanco Animal Health Incorporated unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $3.00M.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month as first filed |
|---|---|---|
| 2025-12-31 | $37.00M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $7.00M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $2.00M 10-K · filed 2026-02-24 | |
| 2022-12-31 | $3.00M 10-K · filed 2025-02-25 | |
| 2021-12-31 | $0.00 10-K · filed 2024-02-26 | |
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | $100.00K 10-K · filed 2021-03-01 |
| 2019-12-31 | $1.00M 10-K · filed 2022-02-28 | $1.30M 10-K · filed 2020-02-28 |
| 2018-12-31 | $2.20M 10-K · filed 2021-03-01 | |
| 2017-12-31 | $7.90M 10-K · filed 2020-02-28 | |
| 2016-12-31 | $7.40M 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |